Obesity Drugmaker Leads 2 Biotech Startups Eyeing IPOs
By Jade Martinez-Pogue · April 13, 2026, 8:47 PM EDT
Two biotechnology startup companies on Monday filed plans for their public debuts, with obesity-focused Kailera Therapeutics planning to raise an estimated $500 million in its initial public offering and protein biomarker...
To view the full article, register now.